Gitte Pugholm Aabo proposed as new Chair of the Board of Directors of Tobii Dynavox

Report this content

The Nomination Committee of Tobii Dynavox has now completed its recruitment process for the 2024 Annual General Meeting.

Gitte Pugholm Aabo is proposed as the new Chair of the Board, who would thereby succeed Åsa Hedin, who in December 2023 informed the Nomination Committee that she is not available for re-election at the 2024 Annual General Meeting.

 

Gitte Pugholm Aabo, is a Danish citizen, born in 1967 and holds an MBA from Copenhagen Business School. She has had a long career in the pharmaceutical industry and in medical technology. In 2023, she left her position as CEO of the Danish hearing aid company GN Hearing, which is part of the GN Store Nord Group. Prior to that, Gitte worked for the Danish pharmaceutical company Leo Pharma for 27 years, of which the last 11 years as President and CEO. From 2024, Gitte plans to devote herself entirely to board work.

 

"We are very pleased that Gitte Pugholm Aabo has accepted our offer to be nominated as the new Chair of the Board of Tobii Dynavox. Gitte has successfully led fast-growing companies in many different markets. Together with strong leadership, she is very well placed to lead the Board during the next phase of growth for Tobii Dynavox," said Jan Andersson, Chair of the Nomination Committee.

 

The Nomination Committee will also propose re-election of the Board members Carl Bandhold, Maarten Barmentlo, Henrik Eskilsson, Charlotta Falvin and Caroline Ingre.

 

The Nomination Committee's other proposals will be presented in the notice to the Annual General Meeting 2024.

 

 

For further information, please contact:

Jan Andersson
Chair of the Nomination Committee
Phone: +46 (0)76 139 55 00

Contact

Linda Tybring, CFO, Tobii Dynavox, phone: +46 (0) 7068 14 980, email:  linda.tybring@tobiidynavox.com 

About Tobii Dynavox

Tobii Dynavox is the global leader in assistive communication. Our custom designed solutions enable people with disabilities such as cerebral palsy, ALS, autism and spinal cord injury to communicate with a voice of their own, develop literacy skills and live more independently. To date, hundreds of thousands of people worldwide have benefited from our integrated solutions, which include hardware, software, clinically developed language systems, special education tools, training, and dedicated support. Using AI-based speech synthesis, we offer users a personalized voice identity in over 30 languages, for children and adults. We offer an extensive funding support system to reach as many people as possible. Headquartered in Sweden, Tobii Dynavox employs over 600 people with offices in the US, the UK, Ireland, Norway, Denmark, Belgium, France and China, and reselling partners in 60+ countries. For more information, please visit our website: Tobii Dynavox Investor Relations